Walter Reinisch
- Genetics top 0.1%
- Inflammatory Bowel Disease 61
- Epidemiology top 0.5%
- Microscopic Colitis 44
- Autoimmune and Inflammatory Disorders 6
- Mycobacterium research and diagnosis 5
- Gastroenterology top 1%
- Celiac Disease Research and Management 5
- Immunology top 1%
- Immunodeficiency and Autoimmune Disorders 8
- Hepatology top 2%
-
- Eosinophilic Esophagitis 8
- Helicobacter pylori-related gastroenterology studies 8
- Co-authors
- Simon TravisGerassimos J. MantzarisSéverine VermeireWilliam J. SandbornJean–Frédéric ColombelAxel DignaßGert Van AsscheJames O. Lindsay
- Cited by
- GeneticsEpidemiologyGastroenterology
- Partner nations
- AustriaUnited StatesFrance
In The Last Decade
Walter Reinisch
68 papers receiving 7.0k citations
Hit Papers
Peers
Comparison fields: 5 of 118
- Genetics 5.3k
- Epidemiology 4.1k
- Gastroenterology 538
- Immunology 1.8k
- Hepatology 473
Countries citing papers authored by Walter Reinisch
This map shows the geographic impact of Walter Reinisch's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Walter Reinisch with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Walter Reinisch more than expected).
Fields of papers citing papers by Walter Reinisch
This network shows the impact of papers produced by Walter Reinisch. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Walter Reinisch. The network helps show where Walter Reinisch may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Walter Reinisch, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 2 | |
| 3 | 2024 | 0 | |
| 4 | 2019 | 49 | |
| 5 | 2015 | 29 | |
| 6 | 2015 | 68 | |
| 7 | 2014 | 5 | |
| 8 | 2013 | 328 | |
| 9 | 2013 | 14 | |
| 10 | Secukinumab, a human anti-IL-17A monoclonal antibody, for moderate to severe Crohn's disease: unexpected results of a randomised, double-blind placebo-controlled trialbreakdown → | 2012 | 1156 |
| 11 | Second European evidence-based consensus on the diagnosis and management of ulcerative colitis Part 2: Current managementbreakdown → | 2012 | 1248 |
| 12 | Adalimumab for induction of clinical remission in moderately to severely active ulcerative colitis: results of a randomised controlled trialbreakdown → | 2011 | 683 |
| 13 | 2007 | 131 | |
| 14 | Nodular regenerative hyperplasia with portal hypertension in patients with inflammatory bowel disease treated with azathioprine | 2006 | 3 |
| 15 | 2006 | 48 | |
| 16 | 2006 | 5 | |
| 17 | 2004 | 4 | |
| 18 | 2003 | 60 | |
| 19 | 2002 | 215 | |
| 20 | 2001 | 52 |
About Walter Reinisch
Walter Reinisch is a scholar working on Genetics, Epidemiology and Gastroenterology, having authored 71 papers that have together received 7.2k indexed citations. Recurring topics across this work include Inflammatory Bowel Disease (61 papers), Microscopic Colitis (44 papers), Eosinophilic Esophagitis (8 papers), Immunodeficiency and Autoimmune Disorders (8 papers), Helicobacter pylori-related gastroenterology studies (8 papers), Autoimmune and Inflammatory Disorders (6 papers), Mycobacterium research and diagnosis (5 papers) and Celiac Disease Research and Management (5 papers). The work is most often cited by research in Genetics (5.3k citations), Epidemiology (4.1k citations) and Gastroenterology (538 citations). Walter Reinisch has collaborated with scholars based in Austria, United States and France. Frequent co-authors include Simon Travis, Gerassimos J. Mantzaris, Séverine Vermeire, William J. Sandborn, Jean–Frédéric Colombel, Axel Dignaß, Gert Van Assche, James O. Lindsay, Eduard F. Stange and Laurent Peyrin‐Biroulet. Their work appears in journals such as Gastroenterology, Gut and Journal of Hepatology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.